SCHEMBL844906

SCHEMBL844906

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3c[nH]cn3)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1c[nH]cn1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.44
HCRTR2 O43614 3/20 0.44
GAA P10253 1/20 0.41
PABPC1 P11940 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
EP300 Q09472 1/20 0.38
CREBBP Q92793 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845714 0.94 HCRTR1 (0.40) HCRTR1HCRTR2GAAPABPC1ALDH1A1
SCHEMBL845391 0.83 GAA (0.42) HCRTR1HCRTR2GAAPABPC1ALDH1A1
SCHEMBL845195 0.83 HCRTR1 (0.46) HCRTR1HCRTR2GAAPABPC1ALDH1A1
SCHEMBL845725 0.82 RHOC (0.45) PABPC1ALDH1A1CYP2C9CYP2C19HTT
SCHEMBL845164 0.79 ALDH1A1 (0.44) HCRTR1HCRTR2PABPC1ALDH1A1CYP2C9
SCHEMBL845286 0.79 ALDH1A1 (0.48) HCRTR1HCRTR2GAAPABPC1ALDH1A1
SCHEMBL845393 0.79 GAA (0.47) HCRTR1HCRTR2GAAPABPC1ALDH1A1
SCHEMBL845205 0.79 ALDH1A1 (0.56) HCRTR1HCRTR2PABPC1ALDH1A1CYP2C9
SCHEMBL845226 0.79 ALDH1A1 (0.56) HCRTR1HCRTR2PABPC1ALDH1A1CYP2C9
SCHEMBL15116912 0.79 ALDH1A1 (0.56) HCRTR1HCRTR2PABPC1ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed